MicroRNA-26b represses colon cancer cell proliferation by inhibiting lymphoid enhancer factor 1 expression

Molecular Cancer Therapeutics

Volumn 13, Issue 7, 2014, Pages 1942-1951

  Zhang, Zichao ^a,e   Kim, Kyoung Hyun ^c   Li, Xiao ^a   Moreno, Myriam ^a   Sharp, Thad ^a   Goodheart, Michael J ^b   Safe, Stephen ^d   Dupuy, Adam J ^b   Amendt, Brad A ^a,b  

^a UNIVERSITY OF IOWA   (United States)

^b UNIVERSITY OF IOWA   (United States)

^c UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^d TEXAS A AND M HEALTH SCIENCE CENTER   (United States)

^e MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN D1; LYMPHOID ENHANCER FACTOR 1; MICRORNA; MICRORNA 26B; MYC PROTEIN; UNCLASSIFIED DRUG; LEF1 PROTEIN, HUMAN;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CANCER CELL LINE; CANCER GROWTH; CELL PROLIFERATION; COLON CANCER; CONTROLLED STUDY; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; ANIMAL; BIOSYNTHESIS; COLON TUMOR; GENETIC TRANSFECTION; GENETICS; HEK293 CELL LINE; METABOLISM; NUDE MOUSE; PATHOLOGY; TUMOR CELL LINE; XENOGRAFT;

ANIMALS; CELL LINE, TUMOR; CELL PROLIFERATION; COLONIC NEOPLASMS; HEK293 CELLS; HETEROGRAFTS; HUMANS; LYMPHOID ENHANCER-BINDING FACTOR 1; MALE; MICE; MICE, NUDE; MICRORNAS; TRANSFECTION;

EID: 84904211238     PISSN: 15357163     EISSN: 15388514     Source Type: Journal    
DOI: 10.1158/1535-7163.MCT-13-1000     Document Type: Article

References (44)

1. He L, Hannon GJ. MicroRNAs: small RNAs with a big role in gene regulation. Nat Rev Genet 2004;5:522-31. (Pubitemid 38868508)
2. Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004;116:281-97.
3. Nelson P, Kiriakidou M, Sharma A, Maniatak E, Mourelatos Z. The microRNA world: small is mighty. Trends Biochem Sci 2003;28:534-40. (Pubitemid 38366279)
4. Nana-Sinkam SP, Croce CM. Clinical applications for microRNAs in cancer. Clin Pharmacol Ther 2013;93:98-104.
5. Mendell JT, Olson EN. MicroRNAs in stress signaling and human disease. Cell 2012;148:1172-87.
6. Visone R, Croce CM. MiRNAs and cancer. AJP 2009;174:1131-8.
7. Zhang B, Pan X, Cobb GP, Anderson TA. microRNAs as oncogenes and tumor suppressors. Dev Biol 2007;302:1-12. (Pubitemid 46096921)
8. Esquela-Kerscher A, Slack FJ. Oncomirs-microRNAs with a role in cancer. Na Rev 2006;6:259-69.
9. Liu XX, Li XJ, Zhang B, Liang YJ, Zhou CX, Cao DX, et al. MicroRNA-26b is underexpressed in human breast cancer and induces cell apoptosis by targeting SLC7A11. FEBS Lett 2011;585:1363-7.
10. Rahbari R, Holloway AK, He M, Khanafshar E, Clark OH, Kebebew E. Identification of differentially expressed microRNAs in parathyroid tumors. Ann Surg Oncol 2010;18:1158-65.
11. Danielsson K, Ebrahimi M, Wahlin YB, Nylander K, Boldrup L. Increased levels of COX-2 in oral lichen planus supports an autoimmune cause of the disease. J Eur Acad Dermatol Venereol. 2012;26:1415-9.
12. Wu N, Zhao X, Liu M, Liu H, Yao W, Zhang Y, et al. Role of microRNA-26b in glioma development and its mediated regulation on EphA2. PloS ONE 2011;6:e16264.
13. Kent OA, Mendell JT. A small piece in the cancer puzzle: microRNAs as tumors suppressors and oncogenes. Oncogene 2006;25:6188-96. (Pubitemid 44527849)
14. Weidhaas JB, Babar I, Nallur SM, Trang P, Roush S, Boehm M, et al. MicroRNAs as potential agents to alter resistance to cytotoxic anticancer therapy. Cancer Res 2007;67:11111-6. (Pubitemid 350248533)
15. Jeong SH, Wu HG, Park WY. LIN28B confers radio-resistance through the posttranscriptional control of KRAS. Exp Mol Med 2009;41:912-8.
16. Arora H, Qureshi R, Jin S, Park AK, Park WY. miR-9 and let-7g enhance the sensitivity to ionizing rediation by suppression of NFKB1. Exp Mol Med 2011;43:298-304.
17. Ma YL, Zhang P, Wang F, Moyer MP, Yang JJ, Liu ZH, et al. Human embryonic stem cells and metastatic colorectal cancer cells shared the common endogenous human microRNA-26b. J Cell Mol Med 2011;15:1941-54.
18. Moon RT, Kohn AD, De Ferrari GV, Kaykas A. Wnt and β-catenin signalling: diseases and therapies. Nature 2004;5:689-99.
19. Paul S, Dey A. Wnt signaling and cancer development: therapeutic implication. Neoplasma 2008;55:165-76.
20. Zhang Z, Florez S, Gutierrez-Hartmann A, Martin JF, Amendt BA. MicroRNAs regulate pituitary development, and microRNA 26b specifically targets lymphoid enhancer factor 1 (Lef-1), which modulates pituitary transcription factor 1 (Pit-1) expression. J Biol Chem 2010;285:34718-28.
21. Kriegl L, Horst D, Reiche JA, Engel J, Kirchner T, Jung A. LEF-1 and TCF4 expression correlate inversely with survival in colorectal cancer. J Translational Medicine 2010;8:123-31.
22. Niemann C, Owens DM, Schettina P, Watt FM. Dual role of inactivating Lef1 mutations in epidermis: tumor promotion and specification of tumor type. Cancer Res 2007;67:2916-21. (Pubitemid 46724824)
23. Rubinson DA, Dillon CP, Kwiatkowski AV, Sievers C, Yang L, Kopinja J, et al. A lentivirus-based system to functionally silence genes in primary mammalian cells, stem cells and transgenic mice by RNA interference. Nat Genet 2003;33:401-6. (Pubitemid 36278858)
24. Lee S-O, Chintharlapalli S, Liu S, Papineni S, Cho SD, Yoon K, et al. p21 expression is induced by activation of nuclear nerve growth factor-induced Bα (Nur77)in pancreatic cancer cells. Mol Cancer Res 2009;7:1169-78.
25. Amendt BA, Sutherland LB, Russo AF. Multifunctional role of the Pitx2 homeodomain protein C-terminal tail. Mol Cel Biol 1999;19:7001-10. (Pubitemid 29441882)
26. Zhang Z, Wlodarczyk BJ, Niederreither K, Venugopalan S, Florez S, Finnell RH, et al. Fuz regulates craniofacial development through tissue specific responses to signaling factors. PLoS ONE 2011;6:e24608.
27. Balaguer F, Moreira L, Lozano JJ, Link A, Ramirez G, Shen Y, et al. Colorectal cancers with microsatellite instability display unique miRNA pro files. Clin Cancer Res 2011;17:6239-49.
28. He TC, Sparks AB, Rago C, Hermeking H, Zawel L, da Costa LT, et al. Identification of c-MYC as a target of the APC pathway. Science 1998;281:1509-12. (Pubitemid 28425575)
29. Shtutman M, Zhurinsky J, Simcha I, Albanese C, D'Amico M, Pestell R, et al. The cyclin D1 gene is a target of the beta-catenin/LEF-1 pathway. Proc Natl Acad Sci USA 1999;96:5522-7. (Pubitemid 29234650)
30. Tetsu O, McCormick F. β-catenin regulates expression of cyclin D1 in colon carcinoma cells. Nature 1999;398:422-6. (Pubitemid 29180374)
31. Li TWH, Ting JHT, Yokoyama NN, Bernstein A, van de Wetering M, Waterman ML. Wnt activation and alternative promoter expression of LEF1 in colon cancer. Mol Cell Biol 2006;26:5284-99. (Pubitemid 44036199)
32. Vogelstein B, Fearon ER, Hamilton SR, Kern SE, Preisinger AC, Leppert M, et al. Genetic Alterations during colorectal-tumor develoment. N Eng J Med 1988;319:525-32.
33. van de Wetering M, Sancho E, Verweij C, de Lau W, Oving I, Hurlstone A, et al. The β-catenin/TCF-4 complex imposes a crypt progenitor phenotype on colorectal cancer cells. Cell 2002;111:241-50. (Pubitemid 35292444)
34. Merrill BJ, Gat U, DasGupta R, Fuchs E. Tcf3 and Lef1 regulate lineage differentiation of multipotent stem cells in skin. Genes Dev 2001;15:1688-705. (Pubitemid 32702590)
35. van Genderen C, Okamura RM, Farinas I, Quo RG, Parslow TG, Bruhn L, et al. Development of several organs that require inductive epithelial-mesenchymal interactions is impared in LEF-1-deficient mice. Genes Dev 1994;8:2691-703.
36. Kim K, Lu Z, Hay ED. Direct evidence for the role pf beta-catenin/LEF-1 signaling pathway in induction of EMT. Cell Biol Int 2002;26:463-76. (Pubitemid 34762099)
37. Hovanes k, Li TWH, Waterman ML. The human LEF-1 gene contains a promoter preferentially active in lymphocytes and encodes multiple isoforms derived from alternative splicing. Nuc Acids Res 2000;28:1994-2003.
38. ODonnell KA, Wentzel EA, Zeller KI, Dang CV, Mendell JT. c-Myc-regulated microRNAs modulate E2F1 expression. Nature 2005;435:839-43.
39. Mestdagh P, Fredlund E, Pattyn F, Schulte JH, Muth D, Vermeulen J, et al. MYCN/c-MYC-induced microRNAs repress coding gene networks associated with poor outcome in MYCN/c-MYC-activated tumors. Oncogene 2010;29:1394-404.
40. Ma L, Young J, Prabhala H, Pan E, Mestdagh P, Muth D, et al. miR-9, a MYC/MYCN-activated microRNA, regulates E-cadherin, and cancer metastasis. Nat Cell Biol 2010;12:247-56.
41. Bui TV, Mendell JT. Myc: maestro of microRNAs. Genes Cancer 2010;1:568-75.
42. Frenzel A, Loven J, Henriksson MA. Targeting MYC-regulated miRNAs to combat cancer. Genes Cancer 2011;1:660-7.
43. Chang TC, Yu D, Lee YS, Wentzel EA, Arking DE, West KM, et al. Widespread microRNA repression by Myc contributes to tumorigenesis. Nat Genet 2008;40:43-50.
44. Kota J, Chivukula RR, O'Donnell KA, Wentzel EA, Montgomery CL, Hwang HW, et al. Therapeutic microRNA delivery suppresses tumorigenesis in a murine liver cancer model. Cell 2009;137:1005-17.